Web Results

Abdullahi v. Pfizer, Inc.

en.wikipedia.org/wiki/Abdullahi_v._Pfizer,_Inc.

The Kano trovafloxacin trial litigation arose out of a clinical trial conducted by the pharmaceutical company Pfizer in 1996 in Kano, Nigeria, during an epidemic of ...

Pfizer lawsuit (re Nigeria) | Business & Human Rights Resource ...

business-humanrights.org/en/pfizer-lawsuit-re-nigeria

The company tested an experimental antibiotic drug, Trovan, on about 200 children during this time. ... A second US lawsuit was filed against Pfizer, Adamu v.

Mystique Is a New Insulin-like Growth Factor-I-regulated PDZ-LIM ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC1073663/

... into pGEX-6P1 prokaryotic expression vector (Pfizer, Inc., Täby, Sweden). .... Incorporated crystal violet was measured by reading its absorbance at A595. ..... [ PubMed]; Brodt, P., Fallavollita, L., Khatib, A. M., Samani, A. A., and Zhang, D. ( 2001). ... Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 t...

Low-frequency drug-resistant HIV-1 and risk of virological failure to ...

jac.oxfordjournals.org/content/early/2014/10/30/jac.dku426.full

Oct 21, 2014 ... Detection of at least one MV versus no MVs was associated with an increased risk of ..... Inc., Pfizer Inc. and GlaxoSmithKline LLC. ..... S. Esser, Klinik für Dermatologie, Universitätsklinikum Essen; H. R. Brodt, HIV Center, ...

Michael Brodt | LinkedIn

www.linkedin.com/in/michael-brodt-0405b1a

View Michael Brodt's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Michael Brodt discover inside ...

June 2010 - GMHC

www.gmhc.org/files/editor/file/r_ti_0610_v2.pdf

Jun 2, 2010 ... as among those receiving continuous therapy (65 vs. 39 .... is published by GMHC, Inc. ... GlaxoSmithKline, Pfizer, Roche .... 33 Rickerts V, Brodt H, Staszewski S, Stille W. Incidence of myocardial infarctions in HIV-infected ...

Presenter and Reviewer Disclosures. - ACC - American College of ...

accscientificsession.acc.org/~/media/ScientificSessions/Migration Content/Education/Presenter Disclosures/ACC12/ACC12 and ACCi2 with TCT Presenter and Reviewer Disclosures.pdf?la=en

Pfizer(SIGNIFICANT),. Astra. Zeneca(SIGNIFICANT), ... Pharmaceuticals,Inc(MO. DEST) ...... Brodt, Chad Robbins. NO. Brooks, Paul ..... Chobanian, Aram V. NO.

Characteristics and Clinical Management of a Cluster of 3 Patients ...

annals.org/article.aspx?articleid=2292050

Jul 21, 2015 ... Sankey V. Williams, MD, Deputy Editor, reports that he has no financial ... MS, Deputy Editor for Statistics, reports that she has stock holdings in Pfizer. ...... Wolf T, Kann G, Becker S, Stephan C, Brodt HR, de Leuw P, et al. ..... All text, graphics, trademarks, and other intellectual property incorporated into the ...

Activity of Daptomycin or Linezolid in Combination with Rifampin or ...

aac.asm.org/content/58/8/4612.full

Linezolid (lots 11C03U04 and 10H10Z16; Pfizer, Inc., NY) was obtained .... Targeted peak concentrations versus concentrations administered in G. mellonella models ...... Fatkenheuer G,; Gareca M,; Rehm SJ,; Brodt HR,; Tice A,; Cosgrove SE.

Aug. 2009 - METHICILLIN-RESISTANT STAPHYLOCOCCUS ...

sciencewatch.com/dr/tt/2009/09-augtt-MIC/

Title: Linezolid vs vancomycin - Analysis of two double-blind studies of patients with ... JM;Price, CS;Forrest, GN;Fakenheuer, G;Gareca, M;Rehm, SJ;Brodt, HR; Tice, .... Pfizer Inc, 235 E 42nd St,Mailstop 235-8-29, New York, NY 10017 USA

More Info

Safety, tolerability, and pharmacokinetics of the anti-IGF-1R ... - NCBI

www.ncbi.nlm.nih.gov

Aug 2, 2009 ... Paul Haluska and Johann S. de Bono received research funds from Pfizer Inc. ... Donghua Yin, Pfizer Global Research and Development, New London, CT, USA. ... Cardillo MR, Monti S, Di Silverio F, Gentile V, Sciarra F, Toscano V. .... Samani AA, Yakar S, Leroith D, Brodt P. The role of the IGF system in ...

The Cerebrospinal Fluid HIV Risk Score for Assessing ... - NCBI

www.ncbi.nlm.nih.gov

Jun 24, 2014 ... Conflict of interest: D.B.C. has been a consultant to Biogen Idec, Inc.; Millennium Pharmaceuticals, Inc.; Bristol-Myers Squibb Co.; Pfizer, Inc.; Genzyme Corp.; Amgen, Inc.; Quintiles, Inc.; ... Brodt HR, Kamps BS, Gute P, et al. .... dimensions of self-reported anxiety and depression: the BDI-II versus the BDI-IA.

The Cerebrospinal Fluid HIV Risk Score for Assessing Central ...

aje.oxfordjournals.org

Jun 24, 2014 ... cART regimens (i.e., protease inhibitor– vs. nonnucleoside re- verse transcriptase ..... Squibb Co.; Pfizer, Inc.; Genzyme Corp.; Amgen, Inc.; Quin- tiles, Inc.; and Sun ... REFERENCES. 1. Brodt HR, Kamps BS, Gute P, et al.